|
시장보고서
상품코드
2032648
두개내 스텐트 시장 보고서 : 유형별, 용도별, 최종 사용자별, 지역별(2026-2034년)Intracranial Stents Market Report by Type (Self-Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization), Application (Intracranial Stenosis, Brain Aneurysm), End User (Hospitals, Ambulatory Surgery Centers), and Region 2026-2034 |
||||||
세계의 두개내 스텐트 시장 규모는 2025년에 5억 2,170만 달러에 이르렀습니다. IMARC Group은 향후 2034년까지 시장 규모가 12억 4,020만 달러에 이를 전망이며, 2026-2034년 CAGR 9.80%로 성장할 것으로 예측했습니다. 다양한 뇌혈관 질환의 유병률 증가, 빠르게 증가하는 고령 인구, 환자 및 의료진들의 비침습적 및 저침습적 시술에 대한 선호도가 높아지는 것이 시장을 이끄는 주요 요인 중 일부입니다.
두개내 스텐트는 니티놀, 스테인리스 스틸 등 생체적합성 재료로 만들어진 소형 관형 의료기기로, 다양한 뇌혈관 질환을 저침습적으로 치료할 수 있도록 특별히 고안된 의료기기입니다. 이들은 여러 영상진단 기술과의 호환성이 향상된 것이 특징이며, 혈관 내를 정확하게 탐색하여 표적 부위에 전개할 수 있습니다. 또한, 개인의 해부학적 특징에 따라 다양한 크기와 모양이 준비되어 있습니다. 가장 일반적인 용도는 뇌의 좁아지거나 약해진 혈관 내에 설치하여 구조적 지지대를 제공하여 혈류를 회복시키는 것입니다. 혈관의 개통성을 유지함으로써 뇌로 가는 혈류를 개선하고, 혈관 협착 및 손상에 따른 뇌졸중 및 기타 합병증 위험을 감소시키는 데 기여합니다. 두개내 스텐트는 두개내 동맥류, 협착증 등 다양한 병태를 치료하기 위한 혈관성형술, 혈관내 코일색전술 등의 수술 및 시술에 폭넓게 활용되고 있습니다. 두개내 스텐트가 가져다주는 장점으로는 혈관의 장기적인 지지, 회복 기간 단축, 입원 기간 단축 등을 들 수 있습니다.
두개내 스텐트 시장 동향 :
세계 시장은 주로 뇌동맥류, 뇌졸중 등 다양한 뇌혈관 질환의 유병률 증가에 의해 주도되고 있습니다. 이는 이러한 질병에 걸리기 쉬운 고령 인구가 빠르게 증가하고 있기 때문입니다. 이에 따라 두개내 스텐트 제조의 지속적인 기술 발전으로 유연성, 탐색성, 방사형 강도를 향상시킨 혁신적이고 진보된 제품이 개발되어 시장을 견인하고 있습니다. 또한, 신경 질환의 조기 진단 및 치료에 대한 관심이 높아지면서 효과적인 치료 솔루션에 대한 수요가 증가하고 있으며, 이에 따라 두개내 스텐트의 채택이 증가하고 있습니다. 또한, 환자와 의료진들 사이에서 회복 기간이 짧은 비침습적, 최소침습적 시술에 대한 선호도가 변화하고 있는 것도 시장 성장의 중요한 요인으로 작용하고 있습니다. 여기에 더해 일부 국가의 정부 기관 및 민간 보험사의 두개내 스텐트 수술에 대한 유리한 상환 정책은 시장 전망을 밝게 하고 있습니다. 또한, 주요 기업 간 시장 입지를 확대하기 위한 다양한 전략적 제휴, 인수합병(M&A) 및 파트너십도 시장을 더욱 활성화시키고 있습니다. 이 외에도 자기공명영상(MRI), 컴퓨터단층촬영(CT), 혈관조영술 등 의료영상기술의 수많은 혁신이 시장에 긍정적인 영향을 미치고 있습니다. 이 외에도 급속한 도시화, 의료비 증가, 특히 개발도상국의 병원 인프라 구축, 광범위한 연구개발(R&D) 활동 등이 시장에 기여하는 요인으로 작용하고 있습니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문
- 지금까지의 세계 두개내 스텐트 시장 동향은 어떠했으며, 향후 몇 년 동안 어떻게 변화할 것인가?
- 세계 두개내 스텐트 시장 성장 촉진요인, 억제요인 및 기회는?
- 각 촉진요인, 억제요인 및 기회는 세계 두개내 스텐트 시장에 어떤 영향을 미칩니 까?
- 주요 지역 시장은?
- 가장 매력적인 두개내 스텐트 시장을 가진 국가는 어디인가?
- 시장 유형별 시장 내역은?
- 두개내 스텐트 시장에서 가장 매력적인 유형은?
- 용도별 시장 현황은?
- 두개내 스텐트 시장에서 가장 매력적인 용도는?
- 최종 사용자별 시장 현황은?
- 두개내 스텐트 시장에서 가장 매력적인 최종 사용자는 누구입니까?
- 세계 두개내 스텐트 시장 경쟁 구도는 어떤가요?
- 세계 두개내 스텐트 시장의 주요 기업은?
목차
제1장 서문
제2장 조사 범위 및 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 두개내 스텐트 시장
제6장 시장 내역 : 유형별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종 사용자별
제9장 시장 내역 : 지역별
제10장 촉진요인, 억제요인 및 기회
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
AJYThe global intracranial stents market size reached USD 521.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,240.2 Million by 2034, exhibiting a growth rate (CAGR) of 9.80% during 2026-2034. The rising prevalence of various cerebrovascular disorders, rapidly growing geriatric population, and shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures represent some of the key factors driving the market.
Intracranial stents refer to small, tubular medical devices that are made from biocompatible materials such as nitinol or stainless steel, specifically designed for treating various cerebrovascular conditions in a less invasive way. They are characterized by improved compatibility with multiple imaging techniques, allowing precise navigation through blood vessels and are therefore deployed at the target site, with various sizes and configurations available to accommodate individual anatomical features. They are most commonly installed within narrowed or weakened blood vessels in the brain to provide structural support and restore blood flow. By maintaining vessel patency, they provide enhanced blood flow to the brain which helps in reducing the risk of stroke and other complications associated with restricted or damaged blood vessels. Intracranial stents find extensive applications i7surgeries and procedures such as angioplasty or endovascular coiling, to treat various conditions including intracranial aneurysms or stenosis. Some of the advantages provided by intracranial stents include long-term support to blood vessels, shorter recovery times, and reduced hospital stays.
INTRACRANIAL STENTS MARKET TRENDS:
The global market is primarily driven by the rising prevalence of various cerebrovascular disorders such as cerebral aneurysms and strokes. This can be attributed to the rapidly growing geriatric population that is more susceptible to developing these ailments. In line with this, continual technological advancements in intracranial stent production resulting in innovative and advanced products with improved flexibility, navigability, and radial strength are fueling the market. Moreover, an enhanced emphasis on early diagnosis and treatment of neurological conditions is propelling the demand for effective treatment solutions, which in turn is resulting in a higher uptake of intracranial stents. Also, the shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures with shorter recovery times is acting as a significant growth-inducing factor for the market. In addition to this, favorable reimbursement policies for intracranial stent procedures by government agencies and private insurance providers in several countries is creating a positive market outlook. The market is further fueled by various strategic collaborations, merger and acquisitions (M&As) and partnerships among key players to expand their market presence. Apart from this, numerous innovations in medical imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and angiography are impacting the market positively. Some of the other factors contributing to the market include rapid urbanization, rising healthcare expenditure, upgradation of hospital infrastructure, particularly in developing countries and extensive research and development (R&D) activities.
KEY MARKET SEGMENTATION:
Type Insights:
- Self-Expanding Stents
- Balloon Expanding Stents
- Stent-Assisted Coil Embolization
Application Insights:
- Intracranial Stenosis
- Brain Aneurysm
End User Insights:
- Hospitals
- Ambulatory Surgery Centers
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intracranial stents. Some of the factors driving the North America intracranial stents market included growing geriatric population, continual technological advancements, shifting preference towards non-invasive and minimally invasive procedures, high healthcare expenditure, etc.
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global intracranial stents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Acandis GmbH, Balt Group, Medtronic Public Limited Company, MicroPort Scientific Corporation, Phenox GmbH, Stryker Corporation, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global intracranial stents market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global intracranial stents market?
- What is the impact of each driver, restraint, and opportunity on the global intracranial stents market?
- What are the key regional markets?
- Which countries represent the most attractive intracranial stents market?
- What is the breakup of the market based on the type?
- Which is the most attractive type in the intracranial stents market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the intracranial stents market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the intracranial stents market?
- What is the competitive structure of the global intracranial stents market?
- Who are the key players/companies in the global intracranial stents market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Intracranial Stents Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Self-Expanding Stents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Balloon Expanding Stents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Stent-Assisted Coil Embolization
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Intracranial Stenosis
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Brain Aneurysm
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgery Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Acandis GmbH
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Balt Group
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Medtronic Public Limited Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 MicroPort Scientific Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Phenox GmbH
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Stryker Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Terumo Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.1 Acandis GmbH
